Screen before you treat. Medical aesthetic clinics should use a structured consultation that evaluates psychological readiness, medical contraindications, medication exposure, skin characteristics, recent procedures, and treatment expectations before administering advanced laser or energy-based treatments. Patients with unrealistic expectations, suspected body dysmorphic disorder, active contraindications, or unwillingness to follow safety instructions should be deferred or declined rather than treated.
The safest screening strategy combines a standardized medical checklist with careful behavioral assessment and objective skin evaluation. A technically suitable device cannot compensate for an unsuitable patient, unsafe medication exposure, or expectations that treatment cannot realistically meet.
Build a Standardized Pre-Treatment Screening Process
Use a documented medical history
Record relevant diagnoses, allergies, previous aesthetic procedures, healing problems, medication changes, and prior adverse reactions to lasers, light, radiofrequency, or ultrasound treatments.
The review should specifically address pregnancy or nursing, active systemic disease, immune compromise, seizure disorders where relevant, and any condition that could impair healing or increase procedural risk.
Screen for absolute or treatment-specific contraindications
For light-based procedures, evaluate for porphyria, photodermatoses, documented photoallergies, and significant photosensitivity.
The clinic should also identify active infection, open wounds, uncontrolled inflammatory skin disease, suspicious lesions, and any condition requiring dermatological assessment before treatment.
Review all medications and topical products
Ask about drugs associated with phototoxic or photosensitive reactions, including certain tetracyclines, quinolones, diuretics, antiarrhythmics, systemic retinoids, and nonsteroidal anti-inflammatory drugs.
Also document topical retinoids, glycolic acid, exfoliants, bleaching products, chemical peels, waxing, and other recent procedures. Medication holds should be based on the specific treatment, current evidence, and the prescribing clinician’s advice rather than applied as an automatic rule.
Identify Psychological and Behavioral Red Flags
Look for disproportionate concern about minor flaws
Warning signs include obsession with a minor or non-existent defect, persistent self-criticism, extreme dissatisfaction with previous treatments, or a belief that one procedure will fundamentally change their life.
These findings may indicate body dysmorphic disorder or another psychological concern. Aesthetic practitioners should not attempt to diagnose such conditions, but should recognize when referral or deferral is appropriate.
Assess whether expectations are achievable
Patients who demand immediate perfection, reject the possibility of incremental improvement, or expect complete correction of anatomical limitations may be unsuitable candidates.
Explain what the proposed device can and cannot change, including limitations related to skin laxity, facial anatomy, scarring, pigmentation, wrinkle depth, and the number of sessions likely to be required.
Observe consultation behavior
Potential red flags include refusal to follow basic instructions, such as removing makeup for assessment, extreme irritation over minor delays, persistent price haggling, or unwillingness to provide accurate medical information.
A single behavior should not automatically exclude a patient. However, repeated patterns of hostility, blame toward every previous practitioner, non-compliance, or inability to accept clinical boundaries justify postponing treatment.
Evaluate willingness to participate in aftercare
Advanced treatments require adherence to sun avoidance, wound care, medication instructions, follow-up, and complication reporting.
A patient who refuses these requirements is not simply “difficult”; they present a predictable safety risk. Treatment should not proceed until expectations and responsibilities are understood and accepted.
Use Objective Evaluation Alongside Interviewing
Establish measurable baseline findings
Document photographs under consistent lighting and, where available, objective measurements such as pore size, wrinkle depth, elasticity, pigmentation, and textural irregularity.
Digital skin analysis can help separate measurable findings from subjective distress and provides a baseline for evaluating progress.
Categorize the patient’s treatment goal
Clarify whether the patient primarily seeks enhancement, rejuvenation, or restoration.
This framework helps align the treatment plan with the patient’s age, skin condition, and desired degree of change rather than allowing vague goals such as “look perfect” or “look completely younger” to drive device selection.
Record the patient’s own words
Document the specific concern, desired outcome, time frame, previous treatments, and stated definition of success.
Clear records help identify changing expectations and provide evidence that the consultation addressed realistic outcomes and informed consent.
Screen for Skin-Specific Risk Factors
Evaluate pigmentation and post-inflammatory hyperpigmentation risk
Patients with darker Fitzpatrick skin types or a personal history of post-inflammatory hyperpigmentation may require conservative settings, test spots, additional preparation, or an alternative treatment.
The risk should be discussed explicitly rather than treated as a minor afterthought.
Check for keloid or hypertrophic scarring
A personal history of keloids or hypertrophic scars warrants heightened caution when the procedure disrupts the epidermis or creates controlled thermal injury.
The clinic should consider whether the proposed treatment is appropriate and whether specialist input is needed.
Assess tanning and recent sun exposure
Recent tanning or intense sun exposure can increase the risk of burns, uneven pigmentation, and delayed recovery.
Mandatory sun avoidance should be part of the pre-treatment protocol, with postponement when the skin is not in a safe condition for treatment.
Identify reactive or compromised skin
Assess for active dermatitis, severe sensitivity, recent sunburn, open lesions, and impaired barrier function.
Do not use an energy-based procedure to “treat through” an unstable skin barrier. Stabilize the condition or refer the patient before proceeding.
Confirm Treatment-Specific Preparation
Provide written instructions
Give patients signed instructions covering sun avoidance, product discontinuation, antiviral prophylaxis when clinically indicated, skin preparation, expected recovery, and warning symptoms.
Written instructions reduce misunderstanding and create a clear record of what the patient was expected to do.
Consider antiviral prophylaxis when indicated
Patients with a relevant history of herpes simplex, particularly when treating susceptible facial or perioral areas, may require antiviral prophylaxis according to the clinician’s protocol.
The decision should be made during screening, not after symptoms appear.
Plan for darker skin types when appropriate
Patients at increased risk of pigmentation may require pretreatment strategies such as clinician-directed pigment management, conservative parameters, or a test area.
Any bleaching or topical preparation should be selected and supervised appropriately, with attention to irritation and compliance.
Check recent procedures and irritants
Confirm whether the patient recently used topical retinoids, glycolic acid, chemical peels, waxing, or other irritating products.
The appropriate interval before treatment depends on the product, procedure, skin condition, and device. If the skin remains irritated, postpone treatment.
Use a Final “Pause or Proceed” Checklist
Verify consent and identity
Before treatment, confirm patient identity, treatment area, medical history, allergies, recent medication changes, and signed informed consent.
Consent must explain expected benefits, limitations, alternatives, likely recovery, and material risks—not merely document that the patient signed a form.
Verify device parameters
Record and independently confirm the device, wavelength or energy modality, spot size, fluence, pulse duration, repetition rate, treatment area, and skin type.
A second-person parameter check is particularly important for CO₂ and Er:YAG lasers, IPL, diode and Nd:YAG systems, HIFU, and microneedle RF.
Verify protective measures
Confirm that cooling systems are functioning and that wavelength-appropriate protective eyewear is worn by the patient and all required personnel.
Equipment preparation should include inspection and cleaning of handpieces, optical lenses, and delivery probes according to the manufacturer’s instructions.
Perform a final skin check
Immediately before treatment, reassess tanning, erythema, infection, irritation, lesions, and any change in health or medication since consultation.
If a new risk has appeared, the correct action is to stop and reassess—not to proceed because the appointment has already been scheduled.
Understanding the Trade-offs
Do not confuse thorough screening with unnecessary exclusion
Overly broad exclusion rules can deny appropriate patients access to beneficial treatment, especially when risks can be reduced through conservative settings, test spots, preparation, or referral.
Screening should be risk-based and treatment-specific, with the rationale documented.
Do not rely on questionnaires alone
A standardized questionnaire improves consistency but cannot replace clinical judgment, visual examination, open-ended questioning, and informed consent.
Patients may omit information unintentionally or may not recognize that a medication, tanning history, or psychological concern is clinically relevant.
Avoid treating price concerns as proof of unsuitability
Price haggling can be a warning sign when it occurs alongside unrealistic expectations, hostility, or refusal to follow instructions. On its own, it is not a medical contraindication.
The decision to defer should be based on the overall pattern of behavior and the patient’s ability to engage safely with care.
Avoid promising outcomes to secure consent
Aggressive marketing or guarantees of perfection undermine informed consent and increase dissatisfaction.
The practitioner should explain uncertainty, the possibility of incomplete response, the need for multiple sessions, and the risk of complications in language the patient can understand.
Know when to refer
A suspected psychological disorder, medically complex history, suspicious lesion, active skin disease, or unclear medication risk may require referral to a dermatologist, physician, or qualified mental-health professional.
Referral is a safety measure, not a judgment about the patient.
How to Apply This to Your Clinic
Use the same documented process for every patient, while tailoring the depth of review to the device, treatment area, skin type, and individual risk profile.
- If your primary focus is patient safety: Use a mandatory checklist covering contraindications, medications, skin condition, recent procedures, sun exposure, consent, cooling, eyewear, and device parameters.
- If your primary focus is reducing dissatisfaction: Define measurable treatment goals, explain anatomical limitations, document expectations, and defer patients who demand guaranteed or immediate perfection.
- If your primary focus is managing psychological risk: Use open-ended consultation questions and standardized screening tools, then refer or decline when suspected BDD, severe distress, or persistent non-compliance makes treatment inappropriate.
- If your primary focus is reducing pigmentary or healing complications: Assess Fitzpatrick skin type, prior hyperpigmentation, keloid history, tanning, skin sensitivity, and preparation requirements before selecting parameters.
- If your primary focus is legal and operational consistency: Require signed, treatment-specific consent and instruction forms, independent parameter verification, and clear documentation of every decision to proceed, postpone, or refer.
A disciplined screening process protects patients, practitioners, and the clinic by ensuring that advanced energy-based treatments are performed only when the medical risk, psychological readiness, and expected outcome are appropriate.
Summary Table:
| Screening Area | Key Considerations |
|---|---|
| Medical History | Record diagnoses, allergies, previous procedures, medication changes, and adverse reactions. Address pregnancy, systemic disease, immune compromise, seizure disorders (if relevant). |
| Contraindications | Evaluate for porphyria, photodermatoses, photosensitivity, active infections, open wounds, inflammatory skin disease, suspicious lesions. |
| Medications & Products | Review phototoxic/photosensitive drugs (tetracyclines, quinolones, diuretics, antiarrhythmics, systemic retinoids, NSAIDs). Note topical retinoids, acids, exfoliants, peels, waxing. |
| Psychological Red Flags | Watch for body dysmorphic disorder signs, unrealistic expectations, non-compliance, hostility, refusal to follow instructions. |
| Skin-Specific Factors | Assess Fitzpatrick skin type, history of PIH or keloids, tanning/sun exposure, reactive/compromised skin. |
| Treatment Preparation | Provide written instructions, antiviral prophylaxis when indicated, conservative settings for dark skin, appropriate intervals after irritants. |
| Final Checklist | Verify consent, identity, device parameters, protective measures, and final skin check before proceeding. |
Elevate patient safety in your clinic with BELIS's advanced aesthetic solutions. Our professional-grade laser systems (Diode, Alexandrite, CO2 Fractional, Erbium, Nd:YAG, Pico), IPL, and PDT devices are designed for precision and reliability. Whether you're looking to expand your services or enhance existing protocols, our OEM/ODM support and comprehensive certifications ensure seamless integration. Partner with BELIS to offer cutting-edge treatments while prioritizing patient care. Contact us today to schedule a consultation and discover how we can elevate your practice.